We didn't delay vaccine results until after US election, says Pfizer CEO

Last week, Pfizer and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis

Pfizer Inc "didn't conspire with anyone" to delay release of efficacy results for the Covid-19 vaccine it developed with German partner BioNTech SE until after the U.S. presidential election, Chief Executive Albert Bourla said on Tuesday.

"The elections were always for us an artificial line. It may have been very important for the president but not for us," Bourla said at New York Times event. "I didn't receive any pressure per se on me to do something that was not appropriate ... I would never do something like that," he said.

Last week, Pfizer and BioNTech said their vaccine was more than